Part 1: An Expert Approach to Cardiorenal Protection in CKD

This two-part program considers the guideline-directed approach to chronic kidney disease (CKD) and how SGLT-2 inhibitors can be used to maximal effect. This webinar, Part 1, is chaired by Professor James Burton, MD (University of Leicester, United Kingdom), with expert insight from a world-renowned faculty, Professor David Wheeler, MD (University College London, UK), Professor Navdeep Tangri, MD (University of Manitoba, Canada), and Professor Carol Pollock, MD (University of Sydney, Australia). Watch this expert panel will unravel the complexities of CKD care in the context of a real-world patient case.
Part two offers a forensic analysis of current practices, revisiting the Part 1 patient case in reflection of expected guideline updates. In this part, the panel provides evidence-based strategies for initiating pharmacological therapies that transcend the theoretical and become actionable in everyday practice.
Elevate your understanding, challenge clinical norms, and be at the forefront of CKD care. Mark your calendar for these pivotal sessions and be part of the movement shaping the future of kidney health.
Part 1 took place on March 11, 2024. Part 2 took place on April 18, 2024.

[@bondardmytro2783]

What is MRST classification?